REYKJAVIK, Iceland, Jan. 2 /PRNewswire-FirstCall/ -. deCODE genetics today announced that its presentation at the 25th Annual JP Morgan Healthcare Conference will be webcast live. deCODE management will provide an update on progress in its drug and diagnostic development programs.
The presentation will be delivered at 11:30am PST/2:30pm EST/7:30pm GMT on Thursday, January 11, 2007 at the Westin St. Francis Hotel in San Francisco. The webcast can be accessed through the Investors page on deCODE's website, http://www.decode.com, and those interested in listening should log on a few minutes in advance in order to download any software or complete any sign-in that may be required. The webcast will be archived for at least one week.
About deCODE
deCODE genetics is a global leader in applying human genetics to develop drugs and diagnostics for common diseases. Our population approach has enabled us to discover and target key biological pathways involved in conditions ranging from heart attack to cancer. We are turning these discoveries into new medicine to better treat and prevent many of the biggest challenges to public health. deCODE is delivering on the promise of the new genetics(SM). Visit us on the web at http://www.decode.com.
Contact: deCODE genetics Stefan Arnason +354 570 1995 ir@decode.is
deCODE geneticsCONTACT: Stefan Arnason of deCODE genetics, +1-354-570-1995, ir@decode.is
Web site: http://www.decode.com/
